Impact of Surfactant protein B (SP-B) on high density lipoprotein (HDL) oxidation index

Published: 21 February 2020| Version 1 | DOI: 10.17632/5rc36wsph8.1
Contributors:
Maura Brioschi, Cristina Banfi, Erica Gianazza, Piergiuseppe Agostoni

Description

Circulating immature surfactant protein B (proSP-B) forms emerged as the most reliable lung-specific circulating marker for alveolar-capillary membrane (ACM) dysfunction and for the overall clinical status of heart failure. Of note, ProSP-B forms were detectable in high-density lipoprotein (HDL) only. Thus we assessed the impact of proSP-B on HDL functions using HDL from healthy subjects enriched with proSP-B produced by a stably transfected CHO cell line that specifically expresses and releases the human proSP-B. In particular, HDL antioxidant capacity (HOI) has been assessed in terms of ability to inhibit air-induced LDL oxidation. Data from this dataset demonstrated that HOI was impaired after proSP-B enrichment (Table1). HOI was also higher in HF patients with respect to age-matched control healthy subjects (Table2).

Files

Steps to reproduce

HOI was measured using a Dichlorofluorescein (DCF)-based fluorescent assay, as described by Breton et al (doi: 10.1016/j.atherosclerosis.2013.10.034). Data are expressed as HDL oxidant index (HOI), calculated as the ratio of fluorescence in the presence of HDL divided by the fluorescence in the absence of HDL.

Categories

Heart Failure

Licence